Sage Bionetworks Launches Two Clinical Studies With Apple’s ResearchKit
Today is a big day for Sage Bionetworks and, we hope, an important day for the medical research community. As part of today’s Apple launch of its ResearchKit platform, Sage Bionetworks announces the availability of two iPhone app-based research studies: Parkinson mPower and Share the Journey. These research studies and the ones we hope will follow in the near future will open up a new front in patient-centered medicine.
Bridge Clinical Studies
Sage Bionetworks is launching two IRB-approved clinical studies that allow massive increases in the scale and diversity of clinical study. Using only mobile devices, we will enroll tens of thousands of participants in clinical studies of Parkinson Disease and post-chemotherapy cognition.
AMP-AD Knowledge Portal
Sage Bionetworks announces the launch of the Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Knowledge Portal, a public repository we created for the sharing of data and results developed within this precompetitive AD target discovery and preclinical validation project.
is to improve the understanding and treatment of human disease through data-driven predictive modeling.
are unified by a common emphasis on leveraging the power of open networks of contributors to solve complex scientific problems.